Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria.

Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria.
Eur Ann Allergy Clin Immunol. 2020 Jun 04;:
Authors: Skander D, Allenova A, Maurer M, Kolkhir P
PMID: 32496030 [PubMed - as supplied by publisher]

Source: European Annals of Allergy and Clinical Immunology - June 6, 2020 Category: Allergy & Immunology Tags: Eur Ann Allergy Clin Immunol Source Type: research